Doctors Health Technology Life Sciences Pharmaceuticals 
HIT Consultant
OCTOBER 25, 2022
Contributing factors to this included larger trial sizes, the need to assess health technology, the requirement to provide data on comparative drugs’ effectiveness, and most importantly the high failure rate. A study in 2020 concluded that the estimated median capitalized research and development cost per product was $985 million.
Health Populi
DECEMBER 27, 2021
That a pharmaceutical company executive is speaking on the main stage at CES speaks to digital health’s mainstreaming beyond elite athletes and smartwatches that track activity.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
AUGUST 7, 2023
Sondra Pepe, SVP of Product Management, at AiCure The imperative to enhance access to quality care and research is a central concern gripping both the healthcare and pharmaceutical sectors. But most patients leave that doctor’s appointment knowing that their doctor told them to potentially go look at clinical trials.
HIT Consultant
JUNE 7, 2023
Kayt Leonard, Global Health Care and Life Sciences Strategic Advisor at SAS We hear it every day, right? Getting information from one doctor to another? Many patients do not understand how their healthcare works, or why it is important to embrace preventive care initiatives such as health screenings. questionable.
HIT Consultant
MARCH 15, 2022
OptimizeRx , a provider of point-of-care technology solutions helping patients start and stay on therapy announced a definitive agreement to acquire the EvinceMed platform and related assets. EvinceMed is a provider in delivering end-to-end automation for specialty pharmaceutical transactions. Venture Capital Funding.
Expert insights. Personalized for you.
98 
Let's personalize your content